BFRI - Biofrontera Inc
Biofrontera Inc Logo

BFRI - Biofrontera Inc

https://www.biofrontera-us.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States. The company is headquartered in Woburn, Massachusetts.

52W High
$1.43
52W Low
$0.54
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.50
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
10.55
EV/EBITDA (<8 favorable)
-0.79
EV/Revenue (<3 favorable)
0.17
P/S (TTM) (<3 favorable)
0.23
P/B (<3 favorable)
0.65
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
12.74%
Institutions (25–75% balanced)
21.92%
Shares Outstanding
10,668,400
Float
8,482,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
39,188,000
Gross Profit (TTM)
23,130,000
EPS (TTM)
-1.82
Profit Margin (>10% good)
-0.42%
Operating Margin (TTM) (higher better)
-0.56%
ROE (TTM) (>15% strong)
-5.32%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.15
Momentum
Bearish momentum
Value
-0.0276
Previous
-0.0286
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025